Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Dosage Regimen: Fixed Dose
Drug Dosage Regimen: Overview
Peptic Ulcer Disease IV: Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Insulin: Dosing Regimen and Adverse Effects
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 30, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
James D McFadyen1,2,3, Elizabeth E Gardiner4
1Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (J.D.M.).
No abstract available in PubMed .